Robin Sutherland brings over two decades of executive leadership experience, with 12 years of HR leadership within the biotech industry. Immediately prior to Onxeo, Robin was founding Head of Human Resources and Clinical Research for Renovia in 2017, a company founded to create diagnostics and treatment for women’s pelvic health. Prior to Renovia, Robin has led HR and operations for organizations as diverse as Ironwood Pharmaceuticals and Fidelity Investments’ Veritude, was Chief Operating Officer for Epoch, and was in clinical practice at Massachusetts General Hospital and Lahey Clinic early in her career prior to moving into executive leadership roles. She has edited and published in peer reviewed journals including Work: The Journal of Rehabilitation, SPINE and Neurourology & Urodynamics. Robin has been an active member of Bridgewell’s Board of Directors since 2013 and served as Board Chair for three years. A graduate of Tufts University, she completed coursework with Simmons University (MHA) and Cornell University (Master’s Program in HR Management).